Svar på skriftligt spörsmål om konsekvenserna för en sämre ersättningsnivå för diabetesläkemedel

This procedure concerns a written question about the consequences of reduced reimbursement levels for diabetes medications. It addresses concerns about access to necessary treatments and potential impacts on patients. The question highlights issues related to income support, equality, and the follow-up of medication policies, potentially affecting individuals with diabetes and healthcare providers.